Sub-stratification of type-2 high airway disease for therapeutic decision-making: a ‘bomb' (blood eosinophils) meets ‘magnet' (FeNO) framework

Sub-stratification of type-2 high airway disease for therapeutic decision-making: a ‘bomb' (blood eosinophils) meets ‘magnet' (FeNO) framework

書誌詳細
主要な著者:	Couillard, S, Pavord, I, Heaney, L, Petousi, N, Hinks, T
フォーマット:	Journal article
言語:	English
出版事項:	Wiley 2022

類似資料

FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma
著者:: Couillard, S, 等
出版事項: (2021)

FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma
著者:: Couillard, S, 等
出版事項: (2021)

Longitudinal changes in sputum and blood inflammatory mediators during FeNO suppression testing
著者:: Couillard, S, 等
出版事項: (2022)

Mechanisms of FeNO non-suppression in severe asthma: analysis of sputum type 2 cytokines and chemokines
著者:: Couillard, S, 等
出版事項: (2020)

Feno and blood eosinophils as biomarkers in predicting asthma exacerbations
著者:: Rastogi, S, 等
出版事項: (2017)

Blood eosinophil depletion with mepolizumab, benralizumab and prednisolone in eosinophilic asthma
著者:: Moran, AM, 等
出版事項: (2020)

Eosinophilic phenotypes of airway disease.
著者:: Pavord, I
出版事項: (2013)

Prognostic value of using FeNO to guide step-down treatment decisions in asthma
著者:: Wang, K, 等
出版事項: (2018)

Eosinophils in asthma and airway hyperresponsiveness.
著者:: Brightling, C, 等
出版事項: (2004)

FeNO-based asthma management results in faster improvement of airway hyperresponsiveness
著者:: Katrine Feldballe Bernholm, 等
出版事項: (2018-10-01)

Does a composite score combining peripheral blood eosinophils (PBE) and exhaled nitric oxide (FeNO) accurately predict a sputum eosinophilia?
著者:: Connolly, CM, 等
出版事項: (2017)

Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide
著者:: Couillard, S, 等
出版事項: (2021)

Exhaled Nitric Oxide (FeNO) as a Non-Invasive Marker of Airway Inflammation
著者:: Mitsuru Munakata
出版事項: (2012-01-01)

The Pitfalls of FeNO Testing
著者:: Sujoy Khan
出版事項: (2013-01-01)

The Lancet COPD Commission: broader questions remain
著者:: Petousi, N, 等
出版事項: (2023)

The significance of eosinophilic airway inflammation in asthma
著者:: Pavord, I, 等
出版事項: (2002)

Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma
著者:: Moran, A, 等
出版事項: (2020)

Toward a predict and prevent approach in obstructive airway diseases
著者:: Couillard, S, 等
出版事項: (2023)

Comparison of airway immunopathology of eosinophilic bronchitis and asthma.
著者:: Brightling, C, 等
出版事項: (2003)

The making of the atomic bomb /
著者:: 435392 Rhodes, Richard
出版事項: (1986)

Prognostic value of FeNO-guided assessment to identify steroid-responsive respiratory symptoms
著者:: Wang, K, 等
出版事項: (2018)

Association Between FeNO, Total Blood IgE, Peripheral Blood Eosinophil and Inflammatory Cytokines in Partly Controlled Asthma
著者:: Badar A, 等
出版事項: (2020-10-01)

Current evidence and future research needs for FeNO measurement in respiratory diseases
著者:: Bjermer, L, 等
出版事項: (2014)

Current evidence and future research needs for FeNO measurement in respiratory diseases.
著者:: Bjermer, L, 等
出版事項: (2014)

Update on the Role of FeNO in Asthma Management
著者:: Neveda Murugesan, 等
出版事項: (2023-04-01)

Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis.
著者:: Brightling, C, 等
出版事項: (2000)

Association of general and abdominal obesity with lung function, FeNO, and blood eosinophils in adult asthmatics: Findings from NHANES 2007–2012
著者:: Haoyu Zhang, 等
出版事項: (2023-02-01)

Eosinophils in Asthma and Airway Hyperresponsiveness [3] (multiple letters)
著者:: Brightling, C, 等
出版事項: (2004)

What is the added value of FeNO as T2 biomarker?
著者:: María Celeste Marcos, 等
出版事項: (2022-08-01)

Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma.
著者:: Kulkarni, N, 等
出版事項: (2010)

Exposure to organophosphate flame retardants and plasticizers is positively associated with wheeze and FeNO and eosinophil levels among school-aged children: The Hokkaido study
著者:: Yi Zeng, 等
出版事項: (2023-11-01)

Effects of azithromycin in severe eosinophilic asthma with concomitant monoclonal antibody treatment
著者:: Lavoie, G, 等
出版事項: (2024)

Measuring lung function in airways diseases: current and emerging techniques
著者:: Petousi, N, 等
出版事項: (2019)

Dark sun : the making of the hydrogen bomb /
著者:: 435392 Rhodes, Richard
出版事項: (1995)

Type-2 inflammation: a key treatable trait associated with lung function decline in chronic airways disease
著者:: Petousi, N, 等
出版事項: (2024)

IgE, blood eosinophils and FeNO are not enough for choosing a monoclonal therapy among the approved options in patients with type 2 severe asthma
著者:: Jorge Sánchez, 等
出版事項: (2021-03-01)

The change of FeNO is correlated with asthma control and lung function
著者:: Yanmin Gao, 等
出版事項: (2024-10-01)

FeNO as a biomarker for airway inflammation due to exposure to air pollutants among school children nearby industrial areas in Terengganu
著者:: Kamaruddin, Anis Syafiqah, 等
出版事項: (2019)

Blood eosinophil count (BEC) and fractional exhaled nitric oxide (FeNO) for steroid stewardship in chronic obstructive pulmonary disorder (COPD): A systematic review
著者:: Aditi Dhawan, 等
出版事項: (2024-09-01)

Nasal Airflow Measured by Rhinomanometry Correlates with FeNO in Children with Asthma.
著者:: I-Chen Chen, 等
出版事項: (2016-01-01)